Original filing text · Part I

Item 3 — Quantitative and Qualitative Disclosures About Market Risk

Autolus Therapeutics Plc · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

Under SEC rules and regulations, we are not required to provide the information required by this item in this Quarterly Report on Form 10-Q, as we are considered to be a “smaller reporting company”.